Approximately 30% of primary brain tumors are meningiomas; 90% of these are benign. The remaining 10% have aggressive pathological features and significantly higher recurrence rates. Treatments include surgery, radiation therapy, and other medical therapies. Management of these patients involves vigilant neuroradiological imaging, follow-up visits, symptom management, and ongoing patient and family teaching. Even with aggressive treatment modalities, morbidity and mortality rates remain high.
Deanna Glass-Macenka, is program coordinator in the Department of Neurosurgical Oncology, Johns Hopkins Hospital, Baltimore, MD.
Questions or comments about this article may be directed to Eileen Bohan, RN BSN CNRN, at firstname.lastname@example.org. She is a senior program coordinator in the Department of Neurosurgical Oncology, Johns Hopkins Hospital, Baltimore, MD.
The authors have disclosed that they have no significant relationship with or financial interest in any commercial companies that pertain to this educational activity.